A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Desoxycorticosterone pivalate
Technetium Tc-99m mebrofenin
The excretion of Technetium Tc-99m mebrofenin can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Gadoxetic acid
The excretion of Gadoxetic acid can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Cholecystokinin
The excretion of Cholecystokinin can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Temocapril
The excretion of Temocapril can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Gimatecan
The excretion of Gimatecan can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Atrasentan
The excretion of Atrasentan can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Aripiprazole
The metabolism of Aripiprazole can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Pralsetinib
Dovitinib may decrease the excretion rate of Pralsetinib which could result in a higher serum level.
Desoxycorticosterone pivalate
Fostemsavir
Dovitinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level.
Desoxycorticosterone pivalate
Ripretinib
Dovitinib may decrease the excretion rate of Ripretinib which could result in a higher serum level.
Desoxycorticosterone pivalate
Pralatrexate
Dovitinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Desoxycorticosterone pivalate
Selumetinib
Dovitinib may decrease the excretion rate of Selumetinib which could result in a higher serum level.
Desoxycorticosterone pivalate
Rivaroxaban
Dovitinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Desoxycorticosterone pivalate
Tucatinib
Dovitinib may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Desoxycorticosterone pivalate
Glecaprevir
Dovitinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.
Desoxycorticosterone pivalate
Pibrentasvir
Dovitinib may decrease the excretion rate of Pibrentasvir which could result in a higher serum level.
Desoxycorticosterone pivalate
Lusutrombopag
Dovitinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.
Desoxycorticosterone pivalate
Rucaparib
Dovitinib may decrease the excretion rate of Rucaparib which could result in a higher serum level.
Desoxycorticosterone pivalate
Voxilaprevir
Dovitinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3